Previous 10 | Next 10 |
Oppenheimer says small- to mid-cap biotech stocks could have more downside risk going into the new year after this quarter's pullback while the historically low valuations for large-cap companies could reach the lowest point. More news on: Regeneron Pharmaceuticals, Inc., Alexion Pharmaceu...
HENDERSON, NV / ACCESSWIRE / November 6, 2018 / Big biotech stock buybacks "have destroyed more than $12 billion in value, and generated no positive return in total, at least as a portfolio investment," Leerink analyst Geoffry Porges recently said in a Marketwatch report. Big biotech has sp...
Noteworthy events during the week of November 4 - 10 for healthcare investors. More news on: Dare Bioscience, Inc., EyePoint Pharmaceuticals, Inc., Aduro Biotech, Healthcare stocks news, , Read more ...
Pacific Biosciences of California (NASDAQ: PACB ) +68% on Q3 result . More news on: Pacific Biosciences of California, China Internet Nationwide Financial Services Inc., Exelixis, Inc., Stocks on the move, , Top stock market news, Read more ...
NEW YORK, NY / ACCESSWIRE / November 2, 2018 / Teva shares were skyrocketing on a third quarter financial report that beat analysts’ estimates and a raised outlook. Shares of Sellas Life Sciences were also seeing gains despite any news from the company. The 36% gain for Sellas...
More news on: SELLAS Life Sciences Group, Inc., Globus Maritime Ltd., FormFactor, Inc., Stocks on the move, , Read more ...
CORAL GABLES, FL / ACCESSWIRE / November 1, 2018 / The healthcare sector is often regarded as a hedge from regular market forces. Recent volatility has brought this particular topic to light ahead of US midterm elections . Care in the form of providers, equipment, medicine, technology and...
SELLAS Life Sciences (NASDAQ: SLS ) +20% on positive analyst action . More news on: SELLAS Life Sciences Group, Inc., Attunity Ltd, Floor & Decor Holdings, Inc., Stocks on the move, , Top stock market news, Read more ...
PI +39% on Q2 earnings . More news on: Impinj, Inc., Geron Corporation, GNC Holdings, Inc., Stocks on the move, , Read more ...
NEW YORK, Sept. 13, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications, ...
News, Short Squeeze, Breakout and More Instantly...
SELLAS Life Sciences Group Inc. Company Name:
SLS Stock Symbol:
NASDAQ Market:
SELLAS Life Sciences Group Inc. Website:
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...
- Acute Myeloid Leukemia (AML) is the Second Most Common Hematological Malignancy in Children Often Associated with Poorer Prognosis Compared to Other Pediatric Cancers – - This Recognition Marks SELLAS’ Second RPDD Following the Designation for ALL Received Last Month - -...
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today ...